Ancora Biotech
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2021Stage
Series A | AliveTotal Raised
$60MLast Raised
$60M | 2 mos agoAbout Ancora Biotech
Ancora Biotech is a developer of biotherapeutics for B cell cancers, metabolic diseases, and chronic Hepatitis B infections. It is a service provider supporting clinical development of assets for TeneoTwo, TeneoFour, and TeneoTen. The company oversees the manufacturing and clinical development of these assets, including TeneoTwo’s clinical stage TNB-486 (anti-CD19xCD3); TeneoFour’s preclinical TNB-738, an anti-CD38 enzyme inhibitor and anti-inflammatory poised to enter Phase I clinical studies in Q1 2022; and TeneoTen’s development of preclinical anti-HBVxCD3 for the treatment of chronic hepatitis B. Ancora Biotech was founded in 2021 and is based in Newark, California.
Ancora Biotech Headquarters Location
Newark, California,
United States
Latest Ancora Biotech News
Jul 5, 2022
July 5, 2022 To build on its hematology pipeline in treating blood cancers, Astrazeneca plc is acquiring Teneotwo Inc. in a deal that could reach $1.27 billion. Teneotwo is part of Ancora Biotech LLC, which has some other affiliate Tens in the stable, including Teneofour Inc. That company is developing TNB-738, an anti-CD38 enzyme inhibitor. Teneoten Inc. is developing an anti-HBV/CD3 therapy. Both are available for partnering or sale, Ben Buelow, Ancora co-founder, told BioWorld. He co-founded the company with this father, Roland.
When was Ancora Biotech founded?
Ancora Biotech was founded in 2021.
Where is Ancora Biotech's headquarters?
Ancora Biotech's headquarters is located at Newark.
What is Ancora Biotech's latest funding round?
Ancora Biotech's latest funding round is Series A.
How much did Ancora Biotech raise?
Ancora Biotech raised a total of $60M.
Who are the investors of Ancora Biotech?
Investors of Ancora Biotech include Lightspeed Venture Partners and SR One.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.